CTX-009 (ABL001)
ABL001-P1bC
Phase 2 small_molecule terminated
Quick answer
CTX-009 (ABL001) for P1b: Advanced Solid Tumors is a Phase 2 program (small_molecule) at Compass Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- P1b: Advanced Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated